Thelansis

Osteoporosis Market Outlook Thelansis’s “Osteoporosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Osteoporosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What insights do intervie...

Osteoporosis Market Outlook Thelansis’s “Osteoporosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Osteoporosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Osteoporosis Overview Osteoporosis is a debilitating skeletal disease characterized by the degradation of bone tissue microarchitecture and the loss of bone mass. This condition significantly increases bone fragility, making individuals more susceptible to fractures. The intricate process of bone turnover, normally a delicate balance between resorption and formation, is disrupted in osteoporosis. Osteoclasts play a role in bone removal through acidification and prote...

 Osteoporosis is a skeleton disease characterised by micro-architectural degradation of bone tissue and loss of bone mass. Osteoporosis increases bone fragility and susceptibility to fracture. The average bone turnover involves a balance between bone resorption and bone formation in which osteoclasts remove bone through acidification and proteolytic digestion, and osteoblasts secrete osteoid into the resorption cavity. In postmenopausal women, the rate of bone turnover increases rapidly and remains increased up to 40 years after cessation of ovarian function resulting in progressive bone loss. Risk factors include smoking, low body index, poor nutrition, vitamin D deficiency, low dietary calcium, age, gender, change in hormones, previous fracture, family history of osteoporosis, menopause, certain medications, and other disease conditions. Once osteoporosis is detected early and treated, the outcomes are good. However, if the state remains untreated, it can lead to chronic pain and...